Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Surgical Outcomes in Patients With Endometriosis: A Systematic Review.

Singh SS, Gude K, Perdeaux E, Gattrell WT, Becker CM.

J Obstet Gynaecol Can. 2019 Nov 9. pii: S1701-2163(19)30730-3. doi: 10.1016/j.jogc.2019.08.004. [Epub ahead of print]

2.

Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study.

Lang J, Yu Q, Zhang S, Li H, Gude K, von Ludwig C, Ren X, Dong L.

J Womens Health (Larchmt). 2018 Feb;27(2):148-155. doi: 10.1089/jwh.2017.6399. Epub 2017 Oct 30.

PMID:
29083258
3.

Reevaluating response and failure of medical treatment of endometriosis: a systematic review.

Becker CM, Gattrell WT, Gude K, Singh SS.

Fertil Steril. 2017 Jul;108(1):125-136. doi: 10.1016/j.fertnstert.2017.05.004. Review.

4.

Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.

Ebert AD, Dong L, Merz M, Kirsch B, Francuski M, Böttcher B, Roman H, Suvitie P, Hlavackova O, Gude K, Seitz C.

J Pediatr Adolesc Gynecol. 2017 Oct;30(5):560-567. doi: 10.1016/j.jpag.2017.01.014. Epub 2017 Feb 9.

5.

Synthesis of phylogeny and taxonomy into a comprehensive tree of life.

Hinchliff CE, Smith SA, Allman JF, Burleigh JG, Chaudhary R, Coghill LM, Crandall KA, Deng J, Drew BT, Gazis R, Gude K, Hibbett DS, Katz LA, Laughinghouse HD 4th, McTavish EJ, Midford PE, Owen CL, Ree RH, Rees JA, Soltis DE, Williams T, Cranston KA.

Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12764-9. doi: 10.1073/pnas.1423041112. Epub 2015 Sep 18.

6.

0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.

Gerlinger C, Gude K, Schmelter T, Schaefers M, Endrikat J.

Climacteric. 2015;18(4):512-7. doi: 10.3109/13697137.2015.1036855. Epub 2015 May 22.

PMID:
26000627
7.

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms.

Sutter G, Schmelter T, Gude K, Schaefers M, Gerlinger C, Archer DF.

Menopause. 2014 Mar;21(3):236-42. doi: 10.1097/GME.0b013e31829c12e8.

PMID:
23963309
8.

A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.

Archer DF, Schmelter T, Schaefers M, Gerlinger C, Gude K.

Menopause. 2014 Mar;21(3):227-35. doi: 10.1097/GME.0b013e31829c1431.

PMID:
23963307
9.

One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.

Genazzani AR, Schmelter T, Schaefers M, Gerlinger C, Gude K.

Climacteric. 2013 Aug;16(4):490-8. doi: 10.3109/13697137.2013.783797. Epub 2013 May 11.

PMID:
23531117
10.

An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.

Gerlinger C, Gude K, Hiemeyer F, Schmelter T, Schäfers M.

Menopause. 2012 Jul;19(7):799-803. doi: 10.1097/gme.0b013e31823de8ba.

PMID:
22228322
11.

Recommendation for the collection and analysis of endometrial biopsies for hormone therapies.

Gerlinger C, Gude K, Alinčić-Kunz S, Schäfers M; Bayer Pharma AG - Global Clinical Statistics, Berlin, Germany.

Climacteric. 2012 Feb;15(1):52-8. doi: 10.3109/13697137.2011.587055. Epub 2011 Sep 21.

PMID:
21936612
12.

Surface structure and properties of mixed fumed oxides.

Gun'ko VM, Blitz JP, Gude K, Zarko VI, Goncharuk EV, Nychiporuk YM, Leboda R, Skubiszewska-Zieba J, Osovskii VD, Ptushinskii YG, Mishchuk OA, Pakhovchishin SV, Gorbik PP.

J Colloid Interface Sci. 2007 Oct 1;314(1):119-30. Epub 2007 Jun 13.

PMID:
17570390

Supplemental Content

Support Center